Curis Reports First Quarter 2014 Financial Results
[GlobeNewswire] – LEXINGTON, Mass. — Curis, Inc. , an oncology-focused drug development company developing novel drug candidates for the treatment of human cancers, today reported its financial results for the first quarter … more
View todays social media effects on CRIS
View the latest stocks trending across Twitter. Click to view dashboard